Mark J DiNubile

Invasive candidiasis in cancer patients: observations from a randomized clinical trial.

N. Kartsonis, C. Sable, M. Dinubile, 2005, The Journal of infection.

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

Adriano Lazzarin, Edwin DeJesus, Peter Sklar, 2009, The Lancet.

Treatment with indinavir, efavirenz, and adefovir after failure of nelfinavir therapy.

Joshua Chen, D. Haas, J. Condra, 2003, The Journal of infectious diseases.

Boceprevir for untreated chronic HCV genotype 1 infection.

M. Manns, J. Albrecht, K. Reddy, 2011, The New England journal of medicine.

Plasma gelsolin as a biomarker of inflammation

Mark J DiNubile, 2008, Arthritis research & therapy.

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial.

Jing Zhao, Christine Katlama, Benjamin Young, 2011, The Lancet. Infectious diseases.